Health systems, payers and investors do not buy a feature list, they buy a category with a clear problem attached. Category creation is the decision about which problem your company owns in the market's language, and the public record that makes buyers, analysts and investors repeat your framing back to you.
Hi Founder,
What category creation has produced for HealthTech executives like you:
▋
Your deck proves product depth and says nothing about the category a buyer should place you in, so procurement defaults to comparing you against the wrong incumbents.
You are entering enterprise sales cycles that were already framed by a competitor's language before your pitch arrived.
The language of clinical accuracy does not translate to a CFO, a board or a growth investor.
You are competing with founders who have a weaker product but have been publicly visible for two years.
Nobody in the market knows what specific problem to call you about first.
Typical enterprise health system sales cycle from first conversation to signed contract.
Share of enterprise buyers who say category framing shapes which vendors get shortlisted before any demo.
Typical Series A to B range where category clarity most directly affects fundraising valuation.
We separate what your product actually does from what the market currently calls it, and identify where a clearer category name unlocks faster buyer and investor recognition.
Repositioned around the commercial problem you solve rather than the feature set. The claim is written so a health system CIO, a board member and an investor each understand why you matter.
A deliberate body of writing aimed at buyers and investors: why the old category fails, what procurement teams actually need to see, what evidence a clinical and commercial buyer requires.
Narrative deck framing, category language for the data room, and the one page any board member or analyst needs to justify the category claim.
A named list of health systems, funds, analysts and industry events that fit the category, worked deliberately rather than hoped for.
Preparation for analyst briefings, board conversations and investor updates, including how to hold category language under challenge.
Two to four hours a month, plus the conversations the work produces. The point is to make those conversations happen, not to add another project to your week.
Founders who want a rebrand overnight with no willingness to defend the category claim in front of sceptical buyers or investors. This builds standing over months, not a slogan for a slide.
Audit, positioning and investor-facing surfaces rebuilt.
Publishing starts. Target list built and worked.
First analyst conversations and inbound approaches.
Category language starts appearing in buyer and analyst conversations unprompted.
Deep operating experience with care coordination, roughly a thousand LinkedIn connections, and a public record that mentioned none of the category the company was actually building.
Positioned at the intersection of care operations and technology, with two substantive pieces written for enterprise buyers and investors and a worked target list.
Inbound conversations from three health systems within weeks, then a lead investor commitment inside a quarter, framed around the category the company had defined.
No. It is a commercial decision about which problem you own, backed by evidence a buyer or investor can verify. The language changes because the decision changes, not the other way round.
Why an excellent CV still gets skipped.
Why doctors stop publishing after three weeks.
Why good doctors never get quoted.
Why doctors take the wrong opportunities.
Being known is not the same as being booked.
Pick a time below. Fifteen minutes, private, no pitch. We'll tell you where we think your expertise has the greatest commercial value.